NCT06213324View on ClinicalTrials.gov

Neural Circuit Effects of Ketamine in Depression

PHASE4RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 31, 2024

Primary Completion Date

March 30, 2028

Study Completion Date

April 30, 2028

Conditions
Major Depressive Disorder
Interventions
DRUG

Ketamine

0.5 mg/kg ketamine dissolved in 100 mL saline, delivered intravenously

DRUG

Placebo

Normal saline delivered intravenously

Trial Locations (1)

10029

RECRUITING

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Icahn School of Medicine at Mount Sinai

OTHER